Ultra-high combined positive score and high serum albumin are favorable prognostic biomarkers for immune checkpoint inhibitors in head and neck squamous cell carcinoma.
Yuki SaitoKenya KobayashiOsamu FukuokaToshihiko SakaiKoji YamamuraMizuo AndoKenji KondoPublished in: Head & neck (2023)
CPS ≥90 and albumin >3.5 cases are a subgroup of RMHNSCC that respond extremely well to ICI.
Keyphrases